OBJECTIVES: To calculate the prevalence of the main cardiovascular risk factors (CVRF) after diagnostic confirmation using clinical criteria. To analyse the degree of understanding and monitoring of these factors and to evaluate the association of CVRF with each other, so estimating who is susceptible to intervention. DESIGN: Cross-sectional, descriptive, observational study. SETTING: Population study conducted in Health Area 20 of the Community of Valencia (county of the Low Plain of the River Segura). PATIENTS: People who had lived in this Area for >=20 years. Proportional, multi-stage randomised sampling with definition of sample quotas according to type of residence. SAMPLE SIZE: 2550 people (no reply in first stage: 26%). The second stage involved the clinical confirmation of those identified as suffering from hypertension (HT) (374), hypercholesterolaemia (HCOL) (126), and diabetes (DM) (33). MEASUREMENTS: Patients identified were interviewed for taking blood pressure in the case of those with HT, and blood samples in the case of those with HCOL and DM. The diagnostic criteria recommended by the latest consensus were used. RESULTS: 1886 people (78.1%) took part. Prevalences found: total HT 42+/-2.2%, diagnosed: 11.7+/-1.4; total HCOL 26.6+/-2%; total DM 9.5+/-1.3%. Tobacco dependency was 33.6+/-2.1% and Obesity: 31.6+/-2.1%. Degree of control: HT, 8.6%; HCOL, 21.7%; DM, 56.1%. Association of CVR factors with each other: 25.5% had neither HT nor HCOL and did not smoke. CONCLUSIONS: High prevalence of CVRF in our area, compared with published national findings. Tobacco dependency is less common than at national level. The degree of control is very low and the association of the main CVRF factors for ischaemic cardiopathy reflect that nearly 75% of the population requires a preventive intervention.
OBJECTIVES: To calculate the prevalence of the main cardiovascular risk factors (CVRF) after diagnostic confirmation using clinical criteria. To analyse the degree of understanding and monitoring of these factors and to evaluate the association of CVRF with each other, so estimating who is susceptible to intervention. DESIGN: Cross-sectional, descriptive, observational study. SETTING: Population study conducted in Health Area 20 of the Community of Valencia (county of the Low Plain of the River Segura). PATIENTS: People who had lived in this Area for >=20 years. Proportional, multi-stage randomised sampling with definition of sample quotas according to type of residence. SAMPLE SIZE: 2550 people (no reply in first stage: 26%). The second stage involved the clinical confirmation of those identified as suffering from hypertension (HT) (374), hypercholesterolaemia (HCOL) (126), and diabetes (DM) (33). MEASUREMENTS: Patients identified were interviewed for taking blood pressure in the case of those with HT, and blood samples in the case of those with HCOL and DM. The diagnostic criteria recommended by the latest consensus were used. RESULTS: 1886 people (78.1%) took part. Prevalences found: total HT 42+/-2.2%, diagnosed: 11.7+/-1.4; total HCOL 26.6+/-2%; total DM 9.5+/-1.3%. Tobacco dependency was 33.6+/-2.1% and Obesity: 31.6+/-2.1%. Degree of control: HT, 8.6%; HCOL, 21.7%; DM, 56.1%. Association of CVR factors with each other: 25.5% had neither HT nor HCOL and did not smoke. CONCLUSIONS: High prevalence of CVRF in our area, compared with published national findings. Tobacco dependency is less common than at national level. The degree of control is very low and the association of the main CVRF factors for ischaemic cardiopathy reflect that nearly 75% of the population requires a preventive intervention.
Authors: F Villar Alvarez; A Maiques Galán; M Franch Taix; J R Banegas Banegas; J Vilaseca Canals Journal: Med Clin (Barc) Date: 1999 Impact factor: 1.725
Authors: R Masiá; A Pena; J Marrugat; J Sala; J Vila; M Pavesi; M Covas; C Aubó; R Elosua Journal: J Epidemiol Community Health Date: 1998-11 Impact factor: 3.710
Authors: J R Banegas Banegas; F Rodríguez-Artalejo; J J de la Cruz Troca; B de Andrés Manzano; J del Rey Calero Journal: Med Clin (Barc) Date: 1999-04-17 Impact factor: 1.725
Authors: L Chambless; U Keil; A Dobson; M Mähönen; K Kuulasmaa; A M Rajakangas; H Löwel; H Tunstall-Pedoe Journal: Circulation Date: 1997-12-02 Impact factor: 29.690
Authors: J A Gutiérrez Fuentes; J Gómez-Jerique; A Gómez De La Cámara; M Angel Rubio ; A García Hernández ; I Arístegui Journal: Med Clin (Barc) Date: 2000-12-02 Impact factor: 1.725
Authors: M A Martínez González; A Bueno Cavanillas; M A Fernández García; M García Martín; M Delgado Rodríguez; R Gálvez Vargas Journal: Med Clin (Barc) Date: 1995-09-23 Impact factor: 1.725
Authors: Katharina Wolf-Maier; Richard S Cooper; José R Banegas; Simona Giampaoli; Hans-Werner Hense; Michel Joffres; Mika Kastarinen; Neil Poulter; Paola Primatesta; Fernando Rodríguez-Artalejo; Birgitta Stegmayr; Michael Thamm; Jaakko Tuomilehto; Diego Vanuzzo; Fenicia Vescio Journal: JAMA Date: 2003-05-14 Impact factor: 56.272
Authors: A Maiques Galán; M M Morales Suárez-Varela; M Franch Taix; M D Alfonso Domènech; P Moreno-Manzanaro Goméz; J M García Torán Journal: Aten Primaria Date: 1995-02-15 Impact factor: 1.137
Authors: Francisco J Félix-Redondo; Daniel Fernández-Bergés; José Ríos-Rivera; José F Pérez-Castán; José I Valiente-Rubio; Luis M Molina-Martínez Journal: Aten Primaria Date: 2009-02-03 Impact factor: 1.137